Oculeve Obtains $16,649,997 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1082 Pennsylvannia Ave San Francisco, CA 94107 USA
  • Company Description
    Oculeve, Inc. is developing a novel treatment for Dry Eye, a disease affecting many millions of people worldwide. Oculeve was founded in the heart of Silicon Valley by an expert team of scientists, clinicians, engineers and business executives.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy